-
Product Insights
NewTauopathies – Drugs In Development, 2024
Empower your strategies with our Tauopathies – Drugs In Development, 2024 report and make more profitable business decisions. Tauopathies are a group of neurodegenerative disorders characterized by the aggregation of tau protein into neurofibrillary or gliofibrillary tangles in the human brain. Tau protein normally stabilizes microtubules, which are essential for intracellular transport and communication. However, when tau becomes hyperphosphorylated or misfolded, it dissociates from microtubules and forms insoluble aggregates that impair neuronal function and survival. Tauopathies can present with various clinical...
-
Product Insights
NewFrontotemporal Dementia (FTD) – Drugs In Development, 2024
Empower your strategies with our Frontotemporal Dementia (FTD) – Drugs In Development, 2024 report and make more profitable business decisions. Frontotemporal dementia (FTD) encompasses various brain disorders leading to progressive damage in the frontal and temporal lobes. It manifests in distinct ways: behavioral changes, language difficulties, or movement impairments. Symptoms range from altered social conduct, lack of empathy, and impulsivity to language struggles or motor coordination issues. FTD's exact cause remains unclear, but abnormal protein deposits in the brain are implicated....
-
Sector Analysis
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Neuromodulation Devices Market Report Overview The neuromodulation devices market size was valued at $6.06 billion in 2023. Factors such as deep brain stimulation and spinal cord stimulation will drive the market growth at a CAGR of more than 6% from 2023 to 2033. Neuromodulation is one of the fastest-growing medical device markets. Within the last 10 years, the market has grown exponentially, with spinal cord stimulation being the largest market. Neuromodulation Devices Market Outlook 2023-2033 ($ Billion) Buy Full Report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSHA-120 in Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSHA-120 in Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TSHA-120 in Neuropathy Drug Details:TSHA-120 is under development for the treatment of giant axonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VGL-101 in Neurodegenerative Diseases
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VGL-101 in Neurodegenerative Diseases Drug Details: VGL-101 is under development for the treatment of adult-onset...
-
Sector Analysis
Middle East and Africa (MEA) Mobile Broadband Market Trends and Opportunities, 2023 Update
MEA Mobile Broadband Market Trends and Opportunities Report Overview The total mobile service revenue in MEA is estimated at $93.9 billion in 2023. The market in the MEA region is expected to grow at a CAGR of more than 3% during 2023-2028. The market will be driven by growth in all the device categories over the period. Handsets will be the dominant device category. MEA Mobile Broadband Market Outlook 2023-2028 ($ Billion) Buy the Full Report or Download a Free...
-
Product Insights
Axon Field
Axon Field is a producing field located in Tamaulipas, Mexico. It is being operated by Petroleos Mexicanos. Empower your strategies with our Axon Field report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Company Insights
Aegon – Digital Transformation Strategies
Aegon Digital Transformation Strategies Report Overview Aegon has been focusing on data-led innovation as a part of its digital transformation strategies. The annual ICT spending of Aegon was estimated at $2.4 billion in 2022. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Aegon is a provider of pension plans, life insurance, and asset management services to individuals and families, pension funds, companies, and other institutions. Total ICT Spending 2022 $2.4 billion...
-
Product Insights
United States Neuromodulation Devices Market Share
Neuromodulation Devices (Neurology Devices) United States Market Share report provides quantitative market trends within the Neurology Devices therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Ak Star/ Kuala Lumpur City – Axon Bukit Bintang Residence – Kuala Lumpur
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ak Star/ Kuala Lumpur City - Axon Bukit Bintang Residence - Kuala Lumpur report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...